Cytotoxic T-cell epitopes of the papillomavirus L1-protein...

Details Cytotoxic T-cell epitopes of the papillomavirus L1-protein... Cytotoxic T-cell epitopes of the papillomavirus L1-protein...

2005-06-28

2005-06-28

Salimi, Ali R. (Department: 1648)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Virus or component thereof

C424S186100, C530S300000, C536S023720

Reexamination Certificate

active

06911207

ABSTRACT:
The present invention relates to a papillomavirus T-cell epitope having an amino acid sequence AQIFNKPYW, AGVDNRECI and/or to a functionally active variant thereof, also to their use in diagnostics and therapy.

REFERENCES:
patent: 4777239 (1988-10-01), Schoolnik et al.
patent: 5415995 (1995-05-01), Schoolnik et al.
patent: 5547846 (1996-08-01), Bartsch et al.
patent: 5629161 (1997-05-01), Müller et al.
patent: 5662907 (1997-09-01), Kubo et al.
patent: 5747269 (1998-05-01), Rammensee et al.
patent: 6025163 (2000-02-01), Shamanin et al.
patent: 6183746 (2001-02-01), Urban et al.
patent: 2140591 (1995-07-01), None
patent: 0 375 555 (1990-06-01), None
patent: 0 386 734 (1990-09-01), None
patent: 0 451 550 (1991-10-01), None
patent: 2 279 651 (1995-01-01), None
patent: WO 91/18294 (1991-11-01), None
patent: WO 92/05248 (1992-04-01), None
patent: WO 92/10513 (1992-06-01), None
patent: WO 93/02184 (1993-02-01), None
patent: WO 93/20844 (1993-10-01), None
patent: WO 93/22338 (1993-11-01), None
patent: WO 94/05792 (1994-03-01), None
patent: WO 94/20137 (1994-09-01), None
patent: WO 95/01374 (1995-01-01), None
patent: WO 96/11272 (1996-04-01), None
patent: WO 96/33737 (1996-10-01), None
patent: WO 98/05790 (1998-02-01), None
patent: WO 98/23752 (1998-06-01), None
patent: WO 99/03885 (1999-01-01), None
patent: WO 99/18220 (1999-04-01), None
patent: WO 99/65522 (1999-12-01), None
Altman et al., “Phenotypic Analysis of Antigen-Specific T Lymphocytes,”Science274:94-96 (1996).
Baker et al., “Structures of Bovine and Human Papillomaviruses,”Biophys. J.60:1445-1456 (1991).
De Bruijn et al., “Mechanisms of Induction of Primary Virus-Specific Cytotoxic T Lymphocyte Responses,”Eur. J. Immunol.22:3013-3020 (1992).
De Bruijn et al., “Peptide Loading of Empty Major Histocompatibility Complex Molecules on RMA-S Cells Allows the Induction of Primary Cytotoxic T Lymphocyte Responses,”Eur. J. Immunol.21:2963-2970 (1991).
De Gruijl et al., “Immune Responses Against Huamn Papillomavirus (HPV) Type 16 Virus-Like Particles in a Cohort Study of Women with Cervical Intraepithelial Neoplasia 1 . Differential T-Helper and IgG Responses in Relation to HPV Infection and Disease Outcome,”Journal of General Virology80:399-408 (1999).
Dunbar et al., “Direct isolation, Phenotyping and Cloning of Low-Frequency Antigen-Specific Cytotoxic T Lymphocytes From Peripheral Blood,”Current Biology8:413-416 (1998).
Feltkamp et al., “vaccination with a Cytotoxic T Lymphocyte-Containing Peptide Protects Aganist a Tumor Induced by Human Papillomavirus Type 16-Transformed Cells,”Eur. J. Immunol.23:2242-2249 (1993).
Gossen et al., “Inducible Gene Expression Systems for High Eukaryotic Cells,”Current Opinion in Biotechnology5:516-520 (1994).
Heino et al., “Human Papillomavirus Type 16 Capsids Expose Multipe Type-Restricted and Type-Common Antigenic Epitopes, ”Journal of General Virology76:1141-1153 (1995).
Kast et al., “Role of HLA-A Motifs in Identification of Potential CTL Epitopes in Human Papillomavirus Type 16 E6 and E7 Proteins,”Journal of Immunology152:3904-3912 (1994).
Krchnak et al., “Synthetic Peptides Derived From E7 Region of Human Papillomavirus Type 16 used as Antigens in ELISA,”Journal of General Virology71:2719-2724 (1990).
Müller et al., “Identification of Seroreactive Regions of the Human Papillomavirus Type 16 Proteins E4, E6, E7, and L1,”Journal of General Virology71:2709-2717 (1990).
Müller et al., “Chimeric Papillomavirus-Like Particles,”Virology234:93-111 (1997).
Nieland et al., “Chimeric Papillomavirus Virus-Like Particles Induce a Murine Self-Antigen-Specific Protective and Therapeutic Antitumor Immune Response,”Journal of Cellular Biochemistry71:145-152 (1999).
Parker et al., “Scheme for Ranking Potential HLA-A2 Binding Peptides Based on Independent Binding of Individual Peptide Side-Chains,”Journal of Immunology152:163-175 (1994).
Peng et al., “Papillomavirus Virus-Like Particles Can Deliver Defined CTL Epitopes to the MHC Class I Pathway,”Virology240:147-157 (1998).
Rudolf et al., “Induction of HPV16 Capsid Protein-Specific Human T Cell Responses by Virus-Like Particles,”Biol. Chem.380:335-340 (1999).
Schäfer et al., “Immune Response to Human Papillomavirus 16 L1E7 Chimeric Virus-Like Particles: Induction of Cytotoxic T Cells and Specific Tumor Protection,”Int. J. Cancer81:881-888 (1999).
Sijts et al., “Cytotoxic T Lymphocytes Aganist the Antigen-Processing-Defective RMA-S Tumor Cell Line,”Eur. J. Immunol.22:1639-1642 (1992).
Sijts et al., “Immunodominant Mink Cell Focus-Inducing Murine Leukemia Virus (MuLV)-Encoded CTL Epitope, Identified by Its MHC Class I-Binding Motif, Explains MuLV-Type Specificity of MCF-Directed Cytotoxic T Lymphocytes,”Journal of Immunology152:106-116 (1994).
Tsukui et al., “Interleukin 2 Production in Vitro by Peripheral Lymphocytes in Response to Human Papillomavirus-Derived Peptides: Correlation with Cervical Pathology,”Cancer Research56:3967-3974 (1996).
Zhou et al, “Definition of Linear Antigenic Regions of the HPV 16 L1 Capsid Protein Using Synthetic Virion-Like Particles,”Virology189:592-599 (1992).
Zwicker et al., “Cell-Cycle Regulation of Gene Expression by Transcriptional Repression,”TIG13:3-6 91997).
Chan et al., “Phylogenetic Analysis of 48 Papillomavirus Types and 28 Subtypes and Variants: A Showcase for the Molecular Evolution of DNA Viruses,”Journal of Virology66:5714-5725 (1992).

Affiliated with

Also associated with

Rating

Cytotoxic T-cell epitopes of the papillomavirus L1-protein... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cytotoxic T-cell epitopes of the papillomavirus L1-protein..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytotoxic T-cell epitopes of the papillomavirus L1-protein... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3474714